Equity News Results

  • US STOCKS-Wall St climbs on vaccine bets, Goldman results

    * Goldman Sachs (GS) rises as trading revenue doubles. * Energy, industrial, financial stocks among leaders. * Indexes: Dow +0.8%, S&P 500 +0.9%, Nasdaq +0.7% By Noel Randewich. July 15 - U.S. stocks climbed on Wednesday, with the S&P 500 approaching its highest level in more than four months after promising early data for a potential COVID-19 vaccine and a strong quarterly report from Goldman Sachs.

  • U.S. Stocks Climb After Promising Vaccine Study

    The Dow Jones Industrial Average rose Wednesday, on pace for a fourth straight day of gains, after investors got several doses of good news. Signs of progress toward a coronavirus vaccine by Moderna propelled most corners of the stock market higher. Goldman Sachs Group added to the advance after reporting one of its best quarters by revenue ever.

  • U.S. Stocks Climb After Promising Vaccine Study

    The Dow Jones Industrial Average leapt higher Wednesday, on pace for a fourth straight day of gains, after investors got several doses of good news. Signs of progress toward a coronavirus vaccine by Moderna propelled all corners of the stock market higher. Goldman Sachs Group added to the advance after reporting one of its best quarters by revenue ever.

  • U.S. Stocks Climb After Promising Vaccine Study

    The Dow Jones Industrial Average leapt higher Wednesday as investors cheered promising results from the study of an experimental coronavirus vaccine and solid earnings from Goldman Sachs Group. The blue-chip index jumped 338 points, or 1.3%, to 26973 in early-morning trading. The S&P 500 rose 1.1%, nearly pulling the broad index out of the red for the year, while the Nasdaq Composite advanced 0.9%.

  • U.S. Stocks Open Higher After Promising Vaccine Study

    U.S. stocks rose Wednesday as investors cheered promising results from the study of an experimental coronavirus vaccine while reviewing earnings from more of the nation's biggest financial companies. The S&P 500 advanced 1.1%, signaling a second day of gains for the benchmark index. The Dow Jones Industrial Average added 362 points, or 1.3%, while the Nasdaq Composite Index rose 0.7%.

  • US STOCKS-Futures climb on vaccine hopes, Goldman's huge profit beat

    * Travel-related stocks jump on hopes of vaccine. * UnitedHealth (UNH) up as profit more than doubles. * Futures up: Dow 2.10%, S&P 1.41%, Nasdaq 0.50% By Medha Singh and Devik Jain.

  • FOREX-Dollar hits one-month low; riskier currencies gain on vaccine hopes

    * Aussie, Kiwi dollars gain. * Euro reaches four-month high vs dollar. * Dollar hits monthly low. * Graphic: World FX rates in 2020 https://tmsnrt.rs/2RBWI5E. By Elizabeth Howcroft. July 15 - Risk sentiment revived in currency markets on Wednesday, as progress towards a COVID-19 vaccine helped equities rebound and commodity currencies strengthen, while the dollar fell to a one-month low.

  • Wall Street climbs on vaccine bets, Goldman results

    - U.S. stocks climbed on Wednesday, with the S&P 500 approaching its highest level in more than four months after promising early data for a potential COVID-19 vaccine and a strong quarterly report from Goldman Sachs. Moderna Inc surged 9.2% after a small-scale study showed its experimental COVID-19 vaccine produced high levels of virus-killing antibodies.

  • Wall Street climbs on vaccine bets, Goldman results

    - U.S. stocks climbed on Wednesday, with the S&P 500 approaching its highest level in more than four months after promising early data for a potential COVID-19 vaccine and a strong quarterly report from Goldman Sachs. Moderna Inc surged 9.2% after a small-scale study showed its experimental COVID-19 vaccine produced high levels of virus-killing antibodies.

  • US STOCKS-Futures gain as vaccine hopes offset U.S.-China tensions

    * Futures up: Dow 1.03%, S&P 0.84%, Nasdaq 0.51% By Medha Singh and Devik Jain. U.S. stock index futures rose on Wednesday as investors took heart from signs of progress in developing a COVID-19 vaccine, looking past record daily death rates in some states and brewing tensions between Washington and Beijing.

Search News

Filter Results

Publication Date
Topic
Provider

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.